Drug Use Clinical Trial
Official title:
US-Mexico Binational Quit Using Drugs Intervention Trial (QUIT)
The goal of the US-Mexico Binational Quit Using Drugs Intervention Trial (QUIT) is a multi-site study conducted in the US (East Los Angeles) and Mexico (Tijuana) which aims to reduce drug demand on both sides of the border. The study also aims to build a collaborative partnership between the US and Mexico research teams. The Bi-National QUIT Study will conduct a randomized control trial for risky drug use in several Los Angeles area community health centers. The intent of the trial is to interrupt the progression to addiction for the casual and occasional users of illicit drugs and non-medical users of pharmaceuticals. The Bi-National QUIT protocol will include (1) a computerized assessment of the patient's drug-use history (2) very brief (<5 minutes) clinician advice during a patients pre-arranged medical visit which will be preceded by a computerized assessment of the patient's drug-use history (3) a post visit assessment and video doctor (repeating the very brief clinician advice) in the waiting room (4) two post-visit telephone drug-use counseling sessions to be conducted by drug-health educators at approximately 2 and 6 weeks after the start of the intervention. Follow-up assessments will be conducted at 3 months post-randomization. Parallel activities will take place in the U.S./Los Angeles sites and Mexico/Tijuana sites. Data will be shared between both teams. Data analysis will be collaboratively conducted by both teams.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05468879 -
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
|
N/A | |
Not yet recruiting |
NCT06395129 -
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
|
||
Completed |
NCT02293057 -
Gender-Responsive Drug Use Treatment for Juvenile Justice Girls
|
N/A | |
Completed |
NCT01941108 -
Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care
|
N/A | |
Completed |
NCT01380613 -
Neighborhoods, Networks, Depression, and HIV Risk
|
Phase 2 | |
Withdrawn |
NCT00914719 -
Alcohol Use and Sexual Risk: An Intervention
|
N/A | |
Recruiting |
NCT03671629 -
Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly
|
N/A | |
Completed |
NCT03290391 -
Linking Infectious and Narcology Care-Part II
|
Phase 4 | |
Completed |
NCT04008927 -
A Community-based Intervention Among Active Drug Users in Montpellier
|
N/A | |
Completed |
NCT03627546 -
HCV Seek, Test and Rapid Treatment for Young PWID
|
N/A | |
Not yet recruiting |
NCT03967262 -
Secondary Prevention and Recidivism Reduction in Trauma Patients
|
N/A | |
Completed |
NCT03079856 -
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
|
N/A | |
Completed |
NCT03855410 -
Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention
|
N/A | |
Terminated |
NCT02457949 -
The Impact of Alternative Social Assistance Disbursement on Drug-related Harm
|
N/A | |
Completed |
NCT06238154 -
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
|
Phase 4 | |
Terminated |
NCT04436055 -
Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
|
||
Recruiting |
NCT04717856 -
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
|
N/A | |
Completed |
NCT00249496 -
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
|
N/A | |
Recruiting |
NCT05597865 -
Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents
|
N/A | |
Completed |
NCT05553054 -
Drug Wastage : Observational Study in Intensive Care Units in France
|